Skip to main content

Table 1 Baseline characteristics of the patients receiving Inhalational Versus Intravenous anesthetics

From: Inhalational versus intravenous anesthetic for cerebrovascular accident outcomes after surgical revascularization for adult moyamoya disease

Characteristic

S group(197)

P group(219)

P value

Age (median/IQR)

46(34–52)

44(37–52)

0.438

Male sex, n (%)

90 (45.6)

107 (49)

0.556

BMI (median/IQR)

clinical symptoms:

24.2 (21.9–26.2)

23.7 (21.6–25.7)

0.119

ischemia symptoms, n (%)

hemorrhagic symptoms, n (%)

151 (76.7)

46(23.3)

159 (72.6)

60(27.4)

0.369

Smoking, n (%)

41 (20.8)

53 (24.2)

0.414

Drinking, n (%)

31(15.7 )

43 (19.6)

0.308

DM, n (%)

14 (7.1 )

24 (10.9)

0.233

COPD, n (%)

0 (0)

3 (1.4)

0.250

HTN, n (%)

72 (36.5)

84(38.3)

0.761

CAD, n (%)

4 (2.0)

9 (4.1)

0.268

ASA, (median/IQR)

2(2–2)

2(2–2)

0.199

Preoperative NHISS score, (median/IQR)

1(0–2)

0(0–2)

0.163

Preoperative mRS score, (median/IQR)

1(1–2)

1(1–2)

0.572

Type of surgery, combined, n %

182(92.4)

193(88.1)

0.243

  1. Categorical variables are represented as number (percent). Continuous variables are presented as presented as median/IQR.BMI, body mass index; DM, diabetes mellitus; COPD, chronic obstructive pulmonary disorder; HTN, hypertension; CAD, coronary artery disease; ASA, American Society of Anesthesiology; NHISS, National Institute of Health stroke scale; mRS, Modified Rankin Rating Scale; IQR, interquartile range. P < 0.05 is statistically significant